Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532103 · ClinicalTrials.gov registry record
Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 300
- Enrollment target
NCT00532103 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 300 participants.
The verdict
NCT00532103 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-07 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00532103
The ClinicalTrials.gov registry entry for NCT00532103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00532103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00532103 about?
NCT00532103 is a clinical study titled "Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression". This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when doses are increased in patients with major depressive disorder.
What is the current status of trial NCT00532103?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2007-07. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00532103?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.